Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6651
RLX Technology
RLX
$2.21B
| $1.13M | ﹤0.01% |
530,152
-982,702
| -65% | -$1.98M |
|
6652
CALL
Amphenol
APH
$196B
| $1.13M | ﹤0.01% |
35,000
-1,200
| -3% | -$41.7K |
|
6653
PUT
Beam Global
BEEM
$24.2M
| $1.13M | ﹤0.01% |
72,600
-32,800
| -31% | -$565K |
|
|
EAOM
6654
DELISTED
iShares ESG Aware Moderate Allocation ETF
EAOM
| $1.13M | ﹤0.01% |
45,334
+6,110
| +16% | +$157K |
|
6655
PUT
Northern Oil and Gas
NOG
$2.71B
| $1.13M | ﹤0.01% |
44,600
-62,600
| -58% | -$1.82M |
|
6656
CALL
Saic
SAIC
$5.34B
| $1.13M | ﹤0.01% |
12,100
-12,100
| -50% | -$1.06M |
|
|
CSA
6657
DELISTED
VictoryShares US Small Cap Volatility Wtd ETF
CSA
| $1.13M | ﹤0.01% |
19,950
+531
| +3% | +$31.6K |
|
6658
CALL
Ginkgo Bioworks
DNA
$441M
| $1.12M | ﹤0.01% |
11,810
-1,833
| -13% | -$224K |
|
6659
PUT
Perrigo
PRGO
$1.81B
| $1.12M | ﹤0.01% |
27,700
-8,800
| -24% | -$327K |
|
6660
Alnylam Pharmaceuticals
ALNY
$30.7B
| $1.12M | ﹤0.01% |
7,694
+5,586
| +265% | +$792K |
|
6661
Ambarella
AMBA
$3.3B
| $1.12M | ﹤0.01% |
17,154
-97,449
| -85% | -$7.85M |
|
6662
PUT
HealthEquity
HQY
$8.65B
| $1.12M | ﹤0.01% |
18,300
-23,100
| -56% | -$1.48M |
|
6663
PUT
Sylvamo
SLVM
$1.46B
| $1.12M | ﹤0.01% |
34,360
-34,693
| -50% | -$1.45M |
|
6664
The RealReal
REAL
$1.36B
| $1.12M | ﹤0.01% |
450,733
+163,035
| +57% | +$726K |
|
6665
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.59B
| $1.12M | ﹤0.01% |
11,635
-159,118
| -93% | -$15.7M |
|
6666
PUT
Zevra Therapeutics
ZVRA
$684M
| $1.12M | ﹤0.01% |
251,200
-1,700
| -0.7% | -$7.75K |
|
|
DNMR
6667
CALL
DELISTED
Danimer Scientific, Inc.
DNMR
| $1.12M | ﹤0.01% |
6,140
-3,270
| -35% | -$594K |
|
6668
Distillate International Fundamental Stability & Value ETF
DSTX
$70.9M
| $1.12M | ﹤0.01% |
53,545
-4,222
| -7% | -$95K |
|
6669
CALL
Hercules Capital
HTGC
$3.1B
| $1.12M | ﹤0.01% |
82,900
+57,800
| +230% | +$903K |
|
6670
PUT
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$596M
| $1.12M | ﹤0.01% |
21,400
-3,000
| -12% | -$164K |
|
6671
Groupon
GRPN
$839M
| $1.12M | ﹤0.01% |
98,818
-76,605
| -44% | -$1.26M |
|
6672
CALL
Lennox International
LII
$14.2B
| $1.12M | ﹤0.01% |
5,400
-100
| -2% | -$21.9K |
|
6673
Patria Investments
PAX
$1.83B
| $1.12M | ﹤0.01% |
84,451
-56,629
| -40% | -$893K |
|
6674
CALL
Coca-Cola Europacific Partners
CCEP
$47.6B
| $1.11M | ﹤0.01% |
21,600
-9,600
| -31% | -$491K |
|
6675
CALL
Monarch Casino & Resort
MCRI
$2.23B
| $1.11M | ﹤0.01% |
19,000
-12,700
| -40% | -$891K |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.